Skip to content
Search

Latest Stories

Michelle Riddalls is PAGB's new chief executive

The consumer healthcare association PAGB has appointed Michelle Riddalls as its new chief executive.

Riddalls succeeds John Smith, who has led Proprietary Association of Great Britain since 2015.


The announcement comes in the wake of PAGB’s centenary year and as it embarks on a new five-year strategy focusing on selfcare and industry self-regulation.

Riddalls joined PAGB in 2019 from Pfizer, where she was director of regulatory affairs for its northern European cluster, and served PAGB as senior director of regulatory affairs and advertising services.

Neil Lister, PAGB's president, said: “The PAGB Board is delighted to appoint Michelle Riddalls as chief executive. Michelle has brought a wealth of regulatory experience to PAGB since joining us last year and is perfectly placed to lead the association as it enters its second century as the voice of the consumer healthcare industry.

“The industry has a vital role to play in enabling everyone to care for themselves and their families as effectively as possible – now more than ever, as we face the unprecedented health challenge that is Covid-19.”

Riddalls said: “For more than 100 years, PAGB has worked tirelessly and innovatively to ensure best practice and effective self-regulation in the consumer healthcare industry.

“I am committed to building on that heritage as we embark on the delivery of our new five-year strategy. This is an important time for our industry and I am looking forward to bringing my expertise and experience to my new role at PAGB.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less